Abuse Potential Related Science and Regulatory Perspectives for Psychedelic Drug Product Development
Categories:
Prescription Medicines, Events
Jack Henningfield, PhD, Vice President, Research, Health Policy, and Abuse Liability, Pinney Associates
Presented as part of the NIH Psilocybin Speaker Series, April 22-June 10, 2021